Arcutis Director Sells $121,000 Amid ZORYVE Revenue Surge
A biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
Explore Why Low Cost Matters In Index Funds and how even small fee differences compound over time. Practical tips to keep costs down.
26,485 articlesA biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
Raymond James raises its price target on Phillips 66 to $205, citing a peak in refining margins and geopolitical tail...
A Seattle-based agent is named a 2026 NAR Fair Housing Champion for spearheading a decade-long push to standardize ho...
Qualcomm is trading at a discount to peers while building a strong AI silicon footprint. With a June Investor Day and...
As AI workloads push data-center networks to the limit, seven firms are rising as the backbone of AI connectivity. Th...
Datadog stock climbs after upbeat Q1 results and fresh price targets near $225, underscoring a broader shift to AI-dr...
A single credential from the US government sent Tenable stock racing higher. This article breaks down the catalyst, t...
AMD just struck a landmark deal with a global AI cloud leader. This article breaks down what the contract means for r...
Thursday brought a standout moment for investors tracking stock splits. A dedicated stock-split service captured atte...
Rocket Lab stock surged on upbeat results and new contracts, signaling renewed investor interest. This guide breaks d...
The AI rally has investors chasing chips and data centers, but slow-and-steady Netflix stock might be the overlooked ...
When archer aviation stock plummeted, traders searched for the root causes. This guide breaks down the catalysts, inc...